Patient Services: A Marathon, Not A Sprint
Rob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.
In this video, Rob Truckenmiller, CEO of PharmaCord, covers various trends from patient access to specialty medications in the U.S., including trends that are shaping manufacturer strategies. He also defines the difference between enablement and empowerment when it comes to using AI in patient services, and further shares how emerging technologies could influence the future of specialty pharma services.
Key Learning Objectives
- Learn about PharmaCord, its mission, and what distinguishes the organization in a competitive marketplace.
- Understand how patient journeys are evolving in response to market complexity and how manufacturer needs are shifting, and recognize how PharmaCord is building solutions that align with rising expectations.
- Learn about compliant responses regarding PharmaCord's recent press release and strategic growth initiatives, painting a picture of what lies ahead for the organization and the industry at large.
Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support
May 7th 2025Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring across the industry, prompting greater reliance on specialty pharmacy services and outsourced support.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
